University of Nairobi, Kenya, AIDS Vaccine Initiative (KAVI) Launches Trial of New Vaccine that Potentially Stops HIV

University of Nairobi, Kenya, AIDS Vaccine Initiative (KAVI) Launches Trial of New Vaccine that Potentially Stops HIV

Kenya AIDS Vaccine Initiative (KAVI) is set to launch the clinical human trial of a vaccine that has the potential to stop HIV infecting cells, reports Daily Nation. The Study The clinical trial code named ‘IAVI Woo1 trial.664gp140.Woo1’ will test the vaccine...

Pin It on Pinterest